Context Therapeutics Inc. Contracts & Agreements

49 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Master Services Agreement, dated October 8, 2021, by and between Link Immunotherapeutics, Inc. and Just - Evotec Biologics, Inc. (as assigned to the Company on July 9, 2024)
Context Therapeutics Inc.
Pharmaceuticals
2025
First Amendment to the Development and Manufacturing Services Agreement, dated January 9, 2025, between Lonza Sales AG, Lonza AG and Context Therapeutics Inc
Sales Agreements
Context Therapeutics Inc.
Pharmaceuticals
2025
Description of Securities of Context Therapeutics Inc
Context Therapeutics Inc.
Pharmaceuticals
2025
Sales Agreement, dated as of December 2, 2024, by and between Context Therapeutics Inc. and Leerink Partners LLC
Sales Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2024
LICENSE AGREEMENT
License Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2024
Form of Stock
Stock Agreements
Context Therapeutics Inc.
Pharmaceuticals
2024
Form of Stock Option Agreement (Inducement Grant) of Context Therapeutics Inc
Stock Agreements
Context Therapeutics Inc.
Pharmaceuticals
2024
Employment Agreement, dated August 1, 2024, between
Employment Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2024
ASSET PURCHASE AGREEMENT
Purchase Agreements
Context Therapeutics Inc.
Pharmaceuticals
CA
2024
PRE-FUNDED COMMON STOCK PURCHASE WARRANT CONTEXT THERAPEUTICS INC.
Warrant Agreements
Context Therapeutics Inc.
Pharmaceuticals
2024
Securities Purchase Agreement, dated May 1, 2024, by and between the Company and the Purchasers named therein
Purchase Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2024
Registration Rights Agreement
Registration Rights Agreements
Context Therapeutics Inc.
Pharmaceuticals
2024
Description of Securities of Context Therapeutics Inc
Context Therapeutics Inc.
Pharmaceuticals
2024
Amendment No
Context Therapeutics Inc.
Pharmaceuticals
2024
Termination Agreement of the Clinical Trial Collaboration and Supply Agreement, dated March 21, 2023 between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group
Termination Agreements
Context Therapeutics Inc.
Pharmaceuticals
2023
Amendment No. 1
Context Therapeutics Inc.
Pharmaceuticals
2023
Description of Securities of Context Therapeutics Inc
Context Therapeutics Inc.
Pharmaceuticals
2023
License Agreement, dated November
License Agreements
Context Therapeutics Inc.
Pharmaceuticals
2022
Development and Manufacturing Services Agreement, dated November
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2022
Amendment No. 3 to Process Development Agreement
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2022
Clinical Trial Collaboration and Supply Agreement, dated August 1, 2022, by and between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group
Collaboration Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2022
Amendment No. 2 to Consulting Agreement, dated June 17, 2022, between OncoStrategy, LLC and Context Therapeutics Inc
Consulting Agreements
Context Therapeutics Inc.
Pharmaceuticals
2022
Form of Common Stock Purchase Warrant
Warrant Agreements
Context Therapeutics Inc.
Pharmaceuticals
2022
Employment Agreement
Employment Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2022
Amendment No. 1 to Consulting Agreement, dated March
Consulting Agreements
Context Therapeutics Inc.
Pharmaceuticals
2022
Registration Rights Agreement, dated December 1, 2021, by and between Context Therapeutics Inc. and the investors named therein
Registration Rights Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Securities Purchase Agreement, dated December 1, 2021, by and between Context Therapeutics Inc. and the purchasers named therein
Purchase Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Form of Common Stock Purchase Warrant
Warrant Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Amended and Restated Employment Agreement, dated October 22, 2021, between Context Therapeutics Inc. and Martin Lehr
Employment Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
License Agreement, dated August 23, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
License Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Form of Underwriting Agreement
Underwriting Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Form of Indemnification Agreement between Context Therapeutics Inc. and its officers and directors
Indemnification Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Amendment No. 2 to Process Development Agreement, dated June 3, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Investors Rights Agreement, dated December 22, 2020, among Context Therapeutics LLC and certain investors
Investor Rights Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Form of Stock Certificate of Common Stock
Stock Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Right of First Refusal and Co-Sale Agreement, dated December 22, 2020, among Context Therapeutics LLC and certain investors
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Voting Agreement, dated December 22, 2020, among Context Therapeutics LLC and certain investors
Voting Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Research Collaboration and License Agreement, dated April 6, 2021, between Context Therapeutics LLC and Integral Molecular, Inc
Collaboration Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Process Development Agreement, dated March 6, 2020, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Amendment No. 1 to Process Development Agreement, dated April 21, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Asset Purchase Agreement, dated as of December 15, 2017, between Context Biopharma Inc. and Arno Therapeutics, Inc
Purchase Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Context Therapeutics LLC 2015 Option Plan
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Context Therapeutics Inc. 2021 Long-Term Incentive Plan
Bonus & Incentive Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Form of Stock Option Agreement under the Context Therapeutics Inc. 2021 Incentive Award Plan
Bonus & Incentive Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Form of Stock Grant Agreement under the Context Therapeutics Inc. 2021 Long-Term Incentive Plan
Bonus & Incentive Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Consulting Agreement, dated October 23, 2019, between William Rencher and Context Therapeutics LLC
Consulting Agreements
Context Therapeutics Inc.
Pharmaceuticals
NC
2021
Consulting Agreement, dated February 25, 2021, between Evan Dick and Context Therapeutics LLC
Consulting Agreements
Context Therapeutics Inc.
Pharmaceuticals
PA
2021
Consulting Agreement, dated May 7, 2021, between OncoStrategy, LLC and Context Therapeutics Inc
Consulting Agreements
Context Therapeutics Inc.
Pharmaceuticals
PA
2021
Form of Director Services Agreement
Services Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021